| Distance CE Activities for 2022 |
Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease: Patients with diabetes mellitus (DM) are more likely to have cardiovascular (CV) disease and an increased thrombotic risk; therefore, aggressive management to prevent CV events is crucial. Join Dr. Ashley Lopez for a 45-minute presentation as she addresses emerging evidence on the potential use of dual pathway antithrombotic therapy with aspirin in combination with reduced-dose anticoagulant and stratify the clinical benefit in patients with diabetes mellitus and coronary artery disease.
To learn more about Expanded Role of Rivaroxaban in Patients with Diabetes and Coronary Artery Disease, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
The Utilization of Medications that Augment the Nitric Oxide Pathway in Heart Failure Patients: Join Dr. Brooke Jacobson as she examine the role of medications that augment the nitric oxide pathway in patients with heart failure with reduced ejection fraction. This presentation will begin by describing the background, etiology, and prevalence of heart failure followed by the pathophysiology. The pathophysiology in this presentation will specifically cover how the nitric oxide pathway is altered in patients with heart failure. Current guideline recommendations for optimizing heart failure medications will be reviewed. The presentation will then look at literature available for the nitric oxide augmenting agents. The trials that study the effectiveness of hydralazine/isosorbide (V-HeFT trials and the A-HeFT trial) will be reviewed and analyzed as well as the VICTORIA trial. The VICTORIA trial evaluates the efficacy of the newest agent in this drug class- vericiguat. The presentation will conclude with an evaluation of how these agents should be used in current practice. A treatment algorithm will be included to guide the decision on who should receive these agents.
To learn more about Just Say NO to HFrEF: The Utilization of Medications that Augment the Nitric Oxide Pathway in Patients with Heart Failure, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
A Closer Look at Episodic Migraine Prevention: Join Dr. Nicole Short for this 45-minute presentation where she discusses the characteristics of episodic migraine followed by an explanation of the mechanism of calcitonin gene-related peptide (CGRP) antagonists. An overview of current American Academy of Neurology recommendations and the European Headache Federation guidance on CGRP antagonists for episodic migraine prevention will be discussed. A literature review over the critical trials of injectable CGRP antagonists along with a trial of the first-line agent, topiramate will be presented. The findings of these trials will be compared and contrasted in order to help define the role and place in therapy for CGRP antagonists.
To learn more about A Closer Look at Episodic Migraine Prevention, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV: Join Dr. Leanne Allas for a 45-minute presentation where she will review the use of 2 drug antiretroviral regimens as treatment optimization for persons living with HIV. She will discuss available antiretroviral drug combinations to treat persons with HIV, benefits the switch from the traditional 3-drug antiretroviral regimens to 2-drug antiretroviral regimens, and current switch clinical studies. By the end of this presentation pharmacists will be able to identify patients that may be eligible for a switch to a 2-drug antiretroviral regimen.
To learn more about Two's Company, Three's a Crowd: Optimizing Therapy for People Living with HIV, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
Beta Blockade in Sepsis: Join Dr. Smith for a virtual presentation as he discusses the specific mechanisms in which sepsis and excessive sympathetic stimulation can result in cardiac dysfunction and the potential role ultrashort beta-blockers can have to overcome these negative effects. This session will focus on analyzing recent literature examining beta-blocker therapy in sepsis to identify patient characteristics that may see benefits or harms in receiving beta-blocker therapy.
To learn more about Beta Blockade in Sepsis, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
Link>>>
Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia: Join Dr. Jorns for this virtual home study presentation where she will review background information and current literature on step-down therapy to oral antibiotics in patients with gram-negative bacteremia. The presentation will begin by describing the epidemiology of and risk factors for gram-negative bacteremia. Next, common pathogens and principles of treatment will be reviewed, including several trials pertaining to seven versus fourteen days of antimicrobial therapy. Available literature pertaining to step-down in gram-negative bacteremia will be summarized followed by other pertinent retrospective case studies which include patients with bactermia due to a variety of sources. The presentation will then move into a review and analysis of a trial comparing fluoroquinolones to beta lactams as oral step-down agents as well as a large meta-analysis. The presentation will conclude with evaluation of how step-down to oral antibiotics fits into treatment algorithms for patients with gram-negative bacteremia.
To learn more about Oral Antibiotics for Step-Down Therapy in Uncomplicated Gram-Negative Bacteremia, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
| Additional Distance CE Activities |
Medical Cannabis for Pharmacists: Join Dr. Lauren Palmier for an enlightening virtual home study presentation where she discusses the basic pharmacokinetics and pharmacodynamics of cannabis, and the endocannabinoid system. Considering the recent legalization of marijuana usage for medicinal purposes, this activity educates pharmacists on drug interactions between medical cannabis and pharmaceutical prescription and non-prescription medications, as well as possible side effects and safety concerns.
To learn more about Medical Cannabis for Pharmacists, please click below (if you are an alumnus, please send an email to alumni@uhsp.edu to receive a code to participate in this activity free of charge).
Antithrombotic Therapy Following Transcatheter Aortic Valve Replacement: Join Dr. Allison Wicker as she assesses the available literature to develop an evidence-based recommendation on the optimal antithrombotic regimen following transcatheter aortic valve replacement. Pharmacists can earn .75 contact hours of knowledge-based CE credit at the completion of this activity.
Loading, please wait...
